| 多西紫杉醇联合洛铂二线治疗进展期非小细胞肺癌近期疗效观察 |
| |
| 引用本文： | 康志强,李平.多西紫杉醇联合洛铂二线治疗进展期非小细胞肺癌近期疗效观察[J].第二军医大学学报,2013,34(5):577-578. |
| |
| 作者姓名： | 康志强 李平 |
| |
| 作者单位： | 1. 武警福建省总队医院肿瘤科,福州,350003
2. 第二军医大学长海医院消化内科,上海,200433 |
| |
| 摘 要： | 含铂两药化疗模式是进展期非小细胞肺癌的重要治疗手段,但由于顺铂、卡铂易产生耐药,毒副反应亦大,疗效受到一定的限制。我们2010年开始采用多西紫杉醇联合新型含铂药物洛铂二线治疗经一线治疗失败后的非小细胞肺癌30例,取得较好疗效,现将结果报告如下。
|
| 关 键 词： | 肺肿瘤 非小细胞肺癌 洛铂 多西紫杉醇 |
| 收稿时间： | 2013/3/13 0:00:00 |
| 修稿时间： | 5/3/2013 12:00:00 AM |
Docetaxel combined with Lobaplatin as a second-line treatment for advanced non-small cell lung cancer: an observation of short-term efficacy |
| |
| KANG Zhi-qiang and LI Ping.Docetaxel combined with Lobaplatin as a second-line treatment for advanced non-small cell lung cancer: an observation of short-term efficacy[J].Academic Journal of Second Military Medical University,2013,34(5):577-578. |
| |
| Authors: | KANG Zhi-qiang and LI Ping |
| |
| Institution: | 1. Department of Oncology, Hospital of Armed Police Forces, Fujian Regional Headquarters, Fuzhou 350003, Fujian, China2. Department of Gastroenterology, Changhai Hospital, Second Military Medical University, Shanghai 200433,China*Corresponding author. |
| |
| Abstract: | |
| |
| Keywords: | lung neoplasms non-small cell lung cancer lobaplatin docetaxel |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
| 点击此处可从《第二军医大学学报》浏览原始摘要信息 |
| 点击此处可从《第二军医大学学报》下载免费的PDF全文 |
|
